Kushimoto Shigeki, Gando Satoshi, Saitoh Daizoh, Mayumi Toshihiko, Ogura Hiroshi, Fujishima Seitaro, Araki Tsunetoshi, Ikeda Hiroto, Kotani Joji, Miki Yasuo, Shiraishi Shin-ichiro, Suzuki Koichiro, Suzuki Yasushi, Takeyama Naoshi, Takuma Kiyotsugu, Tsuruta Ryosuke, Yamaguchi Yoshihiro, Yamashita Norio, Aikawa Naoki
Crit Care. 2013 Nov 13;17(6):R271. doi: 10.1186/cc13106.
Abnormal body temperatures (Tb) are frequently seen in patients with severe sepsis. However, the relationship between Tb abnormalities and the severity of disease is not clear. This study investigated the impact of Tb on disease severity and outcomes in patients with severe sepsis.
We enrolled 624 patients with severe sepsis and grouped them into 6 categories according to their Tb at the time of enrollment. The temperature categories (≤ 35.5 °C, 35.6-36.5 °C, 36.6-37.5 °C, 37.6-38.5 °C, 38.6-39.5 °C, ≥ 39.6 °C) were based on the temperature data of the Acute Physiology and Chronic Health Evaluation II (APACHE II) scoring. We compared patient characteristics, physiological data, and mortality between groups.
Patients with Tb of ≤ 36.5 °C had significantly worse sequential organ failure assessment (SOFA) scores when compared with patients with Tb >37.5 °C on the day of enrollment. Scores for APACHE II were also higher in patients with Tb ≤ 35.5 °C when compared with patients with Tb >36.5 °C. The 28-day and hospital mortality was significantly higher in patients with Tb ≤ 36.5 °C. The difference in mortality rate was especially noticeable when patients with Tb ≤ 35.5 °C were compared with patients who had Tb of >36.5 °C. Although mortality did not relate to Tb ranges of ≥ 37.6 °C as compared to reference range of 36.6-37.5 °C, relative risk for 28-day mortality was significantly greater in patients with 35.6-36.5 °C and ≤ 35.5 °C (odds ratio; 2.032, 3.096, respectively). When patients were divided into groups based on the presence (≤ 36.5 °C, n = 160) or absence (>36.5 °C, n = 464) of hypothermia, disseminated intravascular coagulation (DIC) as well as SOFA and APACHE II scores were significantly higher in patients with hypothermia. Patients with hypothermia had significantly higher 28-day and hospital mortality rates than those without hypothermia (38.1% vs. 17.9% and 49.4% vs. 22.6%, respectively). The presence of hypothermia was an independent predictor of 28-day mortality, and the differences between patients with and without hypothermia were observed irrespective of the presence of septic shock.
In patients with severe sepsis, hypothermia (Tb ≤ 36.5 °C) was associated with increased mortality and organ failure, irrespective of the presence of septic shock.
UMIN-CTR ID UMIN000008195.
体温异常(Tb)在严重脓毒症患者中很常见。然而,体温异常与疾病严重程度之间的关系尚不清楚。本研究调查了体温对严重脓毒症患者疾病严重程度和预后的影响。
我们纳入了624例严重脓毒症患者,并根据入组时的体温将他们分为6类。体温类别(≤35.5°C、35.6 - 36.5°C、36.6 - 37.5°C、37.6 - 38.5°C、38.6 - 39.5°C、≥39.6°C)基于急性生理与慢性健康状况评价II(APACHE II)评分的体温数据。我们比较了各组患者的特征、生理数据和死亡率。
入组当天,体温≤36.5°C的患者序贯器官衰竭评估(SOFA)评分显著低于体温>37.5°C的患者。体温≤35.5°C的患者APACHE II评分也高于体温>36.5°C的患者。体温≤36.5°C的患者28天和住院死亡率显著更高。当比较体温≤35.5°C的患者与体温>36.5°C的患者时,死亡率差异尤为明显。尽管与参考范围36.6 - 37.5°C相比,体温≥37.6°C范围的死亡率无相关性,但体温在35.6 - 36.5°C和≤35.5°C的患者28天死亡的相对风险显著更高(优势比分别为2.032和3.096)。当根据是否存在体温过低(≤36.5°C,n = 160;>36.5°C,n = 464)将患者分组时,体温过低的患者弥散性血管内凝血(DIC)以及SOFA和APACHE II评分显著更高。体温过低的患者28天和住院死亡率显著高于无体温过低的患者(分别为38.1%对17.9%和49.4%对22.6%)。体温过低是28天死亡率的独立预测因素,无论是否存在感染性休克,体温过低和无体温过低患者之间均存在差异。
在严重脓毒症患者中,体温过低(Tb≤36.5°C)与死亡率增加和器官衰竭相关,无论是否存在感染性休克。
UMIN - CTR ID UMIN000008195